Orsula V. Knowlton Sells 8,000 Shares of Tabula Rasa HealthCare Inc (TRHC) Stock

Share on StockTwits

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $79.80, for a total transaction of $638,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of NASDAQ TRHC traded up $0.99 during trading on Friday, hitting $74.38. 428,631 shares of the company traded hands, compared to its average volume of 348,759. The company has a current ratio of 0.36, a quick ratio of 0.33 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $1.64 billion, a P/E ratio of -1,859.50, a P/E/G ratio of 6.13 and a beta of 2.85. Tabula Rasa HealthCare Inc has a fifty-two week low of $24.24 and a fifty-two week high of $91.16.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Tuesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.08 by $0.12. The company had revenue of $48.60 million during the quarter, compared to the consensus estimate of $46.73 million. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. Equities research analysts forecast that Tabula Rasa HealthCare Inc will post 0.53 EPS for the current year.

Large investors have recently bought and sold shares of the company. Comerica Bank bought a new stake in shares of Tabula Rasa HealthCare during the second quarter worth about $947,000. Citadel Advisors LLC grew its position in Tabula Rasa HealthCare by 47.0% in the 2nd quarter. Citadel Advisors LLC now owns 8,855 shares of the company’s stock worth $565,000 after purchasing an additional 2,832 shares in the last quarter. Pitcairn Co. bought a new stake in Tabula Rasa HealthCare in the 2nd quarter worth about $285,000. Rhumbline Advisers grew its position in Tabula Rasa HealthCare by 34.5% in the 2nd quarter. Rhumbline Advisers now owns 36,119 shares of the company’s stock worth $2,305,000 after purchasing an additional 9,272 shares in the last quarter. Finally, Wells Fargo & Company MN grew its position in Tabula Rasa HealthCare by 10.2% in the 1st quarter. Wells Fargo & Company MN now owns 17,743 shares of the company’s stock worth $689,000 after purchasing an additional 1,643 shares in the last quarter. 75.15% of the stock is owned by institutional investors.

A number of research firms have weighed in on TRHC. Citigroup boosted their target price on shares of Tabula Rasa HealthCare to $100.00 and gave the stock a “buy” rating in a research note on Thursday. Robert W. Baird boosted their target price on shares of Tabula Rasa HealthCare from $70.00 to $90.00 and gave the company an “outperform” rating in a report on Wednesday, September 19th. BidaskClub lowered shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 15th. Stifel Nicolaus initiated coverage on shares of Tabula Rasa HealthCare in a report on Tuesday, September 11th. They set a “hold” rating and a $95.00 price objective on the stock. Finally, Cantor Fitzgerald initiated coverage on shares of Tabula Rasa HealthCare in a report on Thursday, September 6th. They set an “overweight” rating and a $99.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $71.75.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Read More: Diversification

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.